REGENCELL-COV19 Trademark

Trademark Overview


On Thursday, February 17, 2022, a trademark application was filed for REGENCELL-COV19 with the United States Patent and Trademark Office. The USPTO has given the REGENCELL-COV19 trademark a serial number of 97271526. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Thursday, July 13, 2023. This trademark is owned by REGENCELL BIOSCIENCE LIMITED. The REGENCELL-COV19 trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceuticals and medical preparations; sanitary preparations for medical purposes; pharmaceutical preparations for the treatment of diseases; pharmaceutical preparations for use in the diagnosis, prevention and treatment of COVID-19, coronavirus disease, and respiratory diseases and disorders; preparations for relief of symptoms of common colds, influenza and COVID-19; medical chemical preparations; medical diagnostic preparations; medical drugs; medicines for human purposes; medicinal capsules; therapeutic or medical nutritional preparations; medicinal tea; medicinal herbs; herbal medicines; dietary substances adapted for medical uses; tonics (medicines); Chinese traditional medicines; Chinese traditional medicines for the treatment of COVID-19, coronavirus disease and respiratory diseases; Chinese patent medicines for the treatment of disease; medicinal preparations for the treatment of diseases; biological health food supplements; nutraceutical preparations
regencell-cov19

General Information


Serial Number97271526
Word MarkREGENCELL-COV19
Filing DateThursday, February 17, 2022
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateThursday, July 13, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesPharmaceuticals and medical preparations; sanitary preparations for medical purposes; pharmaceutical preparations for the treatment of diseases; pharmaceutical preparations for use in the diagnosis, prevention and treatment of COVID-19, coronavirus disease, and respiratory diseases and disorders; preparations for relief of symptoms of common colds, influenza and COVID-19; medical chemical preparations; medical diagnostic preparations; medical drugs; medicines for human purposes; medicinal capsules; therapeutic or medical nutritional preparations; medicinal tea; medicinal herbs; herbal medicines; dietary substances adapted for medical uses; tonics (medicines); Chinese traditional medicines; Chinese traditional medicines for the treatment of COVID-19, coronavirus disease and respiratory diseases; Chinese patent medicines for the treatment of disease; medicinal preparations for the treatment of diseases; biological health food supplements; nutraceutical preparations

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, February 23, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameREGENCELL BIOSCIENCE LIMITED
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressCauseway Bay
HK

Trademark Events


Event DateEvent Description
Thursday, July 13, 2023ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Thursday, July 13, 2023ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Thursday, July 13, 2023ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Wednesday, November 30, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, November 30, 2022NON-FINAL ACTION E-MAILED
Wednesday, November 30, 2022NON-FINAL ACTION WRITTEN
Tuesday, November 22, 2022ASSIGNED TO EXAMINER
Wednesday, February 23, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, February 21, 2022NEW APPLICATION ENTERED